BiographyJoe Massaro is Assistant Professor of Biostatistics, Mathematics and Statistics. He currently teaches Applied Statistical Methods in Clinical Trials I and II in the Department of Biostatistics. He has won several teaching awards at the School of Public Health for these courses. Joe currently also serves as Managing Director of Biostatistics and Data Management at Harvard Clinical Research Institute, a contract research organization providing statistical and data management services for the device, pharmaceutical and biotechnology industries. Overall, he has over 15 years experience in the design and statistical analysis of clinical trials, and has co-authored several clinical trials-related articles. Joe also performs longitudinal statistical analysis for the Framingham Heart Study, assessing risk factors for cardiovascular disease and dementia. In addition, he assists in the oversight of data management at the Framingham Heart Study. He has been with the Department of Biostatistics and the Framingham Heart Study since 1998.
- Biostatistician, Framingham Heart Study
- Boston Medical Center
- Boston University, PhD
- Boston University, MA
- Boston College, BA
- Published on 12/1/2017
Qazi S, Massaro JM, Chuang ML, D'Agostino RB, Hoffmann U, O'Donnell CJ. Increased Aortic Diameters on Multidetector Computed Tomographic Scan Are Independent Predictors of Incident Adverse Cardiovascular Events: The Framingham Heart Study. Circ Cardiovasc Imaging. 2017 Dec; 10(12). PMID: 29222122.
- Published on 11/15/2017
Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ. A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2017 Nov 15. PMID: 29142012.
- Published on 11/1/2017
Patel MS, Benjamin EJ, Volpp KG, Fox CS, Small DS, Massaro JM, Lee JJ, Hilbert V, Valentino M, Taylor DH, Manders ES, Mutalik K, Zhu J, Wang W, Murabito JM. Effect of a Game-Based Intervention Designed to Enhance Social Incentives to Increase Physical Activity Among Families: The BE FIT Randomized Clinical Trial. JAMA Intern Med. 2017 Nov 01; 177(11):1586-1593. PMID: 28973115.
- Published on 10/31/2017
Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L. Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Oct 31; 70(18):2213-2223. PMID: 29073947.
- Published on 10/19/2017
Lee JJ, Pedley A, Hoffmann U, Massaro JM, O'Donnell CJ, Benjamin EJ, Long MT. Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study). Am J Cardiol. 2018 Jan 15; 121(2):162-167. PMID: 29146023.
- Published on 10/1/2017
Ferencik M, Pencina KM, Liu T, Ghemigian K, Baltrusaitis K, Massaro JM, D'Agostino RB, O'Donnell CJ, Hoffmann U. Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study. Circ Cardiovasc Imaging. 2017 Oct; 10(10). PMID: 28956774.
- Published on 10/1/2017
Massaro JM, Murabito JM, Au R, Carnahan E, Morgan TS, Murray C, Fisher ES, Nelson EC, Lim SS, D'Agostino RB. Evidence on the Validity of a Comprehensive Health Risk Index and Implications for Ambulatory Care and Population Health Management. J Ambul Care Manage. 2017 Oct/Dec; 40(4):297-304. PMID: 28350635.
- Published on 9/1/2017
Yano Y, O'Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, D'Agostino R, Newman AB, Nasir K, Hofman A, Lehmann N, Dhana K, Blankstein R, Hoffmann U, Möhlenkamp S, Massaro JM, Mahabadi AA, Lima JAC, Ikram MA, Jöckel KH, Franco OH, Liu K, Lloyd-Jones D, Greenland P. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. JAMA Cardiol. 2017 Sep 01; 2(9):986-994. PMID: 28746709.
- Published on 8/26/2017
Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet. 2017 Oct 21; 390(10105):1843-1852. PMID: 28851504.
- Published on 8/5/2017
Doros G, Massaro JM, Kandzari DE, Waksman R, Koolen JJ, Cutlip DE, Mauri L. Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach. Am Heart J. 2017 Nov; 193:35-45. PMID: 29129253.
View 285 more publications:View full profile at BUMC
News & In the Media
- Published on November 10, 2017